8-K: NEVRO CORP

10:01pm, Tuesday, 26'th May 2020
(EDGAR Online via COMTEX) -- false 0001444380 0001444380 2020-05-21 2020-05-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
Nevro (NVRO) received CE mark approval for the Senza Omnia SCS system, which is likely to boost its international presence.
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it has received CE mark approval for
Delayed elective procedures can result in magnified demand for some of BSX’s products in coming months. Boston Scientific is one of the few medtech companies we
Nevro's (NVRO) domestic revenues improved on a year-over-year basis in Q1.

Nevro Corp (NVRO) Q1 2020 Earnings Call Transcript

12:04pm, Wednesday, 06'th May 2020
Image source: The Motley Fool. Nevro Corp (NYSE: NVRO)Q1 2020 Earnings CallMay 5, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGo
Q1 2020 Nevro Corp Earnings Call
Nevro (NVRO) delivered earnings and revenue surprises of 24.27% and 0.98%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE